Contraceptive pill linked to sight loss prevention
Although researchers are unsure as to whether the drug will work on humans, it is hoped that the research may help in the fight to find a cure for blindness.
The research, which will be published in the September issue of The Journal of Neurochemistry, found that a component (Norgestrel) of the contraceptive “Mini Pill” helped stop mice with degenerative eye conditions losing their sight.
People who suffer from the genetic condition Retinitis Pigmentosa lose their sight because light detecting cells in their eyes called photoreceptors begin to die by the time they reach their mid-20s.
In a screening of 1,200 commonly used drugs, Professor Tom Cotter and his team at UCC discovered that Norgestel did more than just provide contraception in mouse models used to study blindness. It prevented the loss of the light detecting cells and the mice retained their sight when the animals were given the drug at a similar concentration used for contraceptive purposes.
“The drug seems to work by stimulating the production of a protein survival factor called FGF from neighbouring cells in the eye that helps the light detecting cells to survive and the animals to see.
“FGF binds to the surface of the light detecting cells and sends a signal to their DNA to up-regulate strong cells survival pathways. It ‘beefs up’ the cells, makes them stronger and better able to resist the destructive effects of the damaged gene that causes the disease.
“At the moment we still don’t know if the drug will work in humans,” said Prof Cotter.
The scientists hope to begin a study next year to see if the protective effects of the “Mini Pill” that are seen in animal models are also experienced by humans.
The research was supported by Science Foundation Ireland, Enterprise Ireland, and Fighting Blindness Ireland. It is being extended to eye conditions such as glaucoma, where the drug shows early promise in the laboratory.
This work will start in October with a grant from the Heath Research Board of Ireland.




